Clinical Studies/Trials

According to St Jude, Dr Robert Hauser’s paper, accepted for publication in the Heart Rhythm Journal is biased and inaccurate, comparing apples with pears and peddling conclusions it’s own analysis cannot reproduce from the data set. Watch this space.

Study into Cancer risk in the first seven years after Metal-on-Metal Hip Replacement compared with other bearings and general population: linkage study between the National Joint Registry of England and Wales and hospital episode statistics.

Biotronik is touting a new paper in European Heart publication, Europace, in which investigators across 57 study sites grade their devices as excellent in 80% of cases.

Crux’s Vena Cava Filter is looking like a winner with good investigator feedback and clinical results as reported at last week’s Society of Interventional Radiology meeting in San Francisco.

Let’s be careful about leaping to too many conclusions about the magic wand that is telemedicine, but this is another paper that suggests remote monitoring of high blood pressure may outperform conventional treatment.

View from the Med: Week 13 is a good read… as ever.

This looks very smart… the idea of combining a central line with an IVC filter seems to make sense, given the need for both in critically ill VTE patients at risk of pulmonary embolism.

OrbusNeich has issued a news release about a clinical study which supports the company’s claim that its clever “pro-healing” stent technology results in a stent which can be indicated in STEMI patients.

Stent company Stentys reckons its self-expanding product addresses a problem raised in acute myocardial application of existing designs.

Two studies presented at ACC 2012 suggest that Medtronic’s Symplicity System for renal denervation shows safe, sustained and significant blood pressure reduction in treatment-resistant hypertension patients.

ACC sees presentation of data from study in severe aortic stenosis patients treated with Edwards Sapien TAVR option. Results are reassuringly equivalent to open heart surgery, suggesting this may be an additional option in patients not suitable for major surgery.

Medtronic announces strong clinical outcomes for its Corevalve product at ACC meeting.

Torax’s LINX system of magnets acting to support the oesophageal sphincter gains FDA clearance.

St Jude’s ICD Lead Data will now be collected and analysed by 3rd party specialist researchers, the Population Health Research Institute.

Everolimus stents appear top dog in long term stent thrombosis meta-analysis.

Clinical trial of minimally invasive spinal fusion system now enrolling in Europe.